BioSpace News Archive

Drug Development

Report: 2021 Could Represent a Major Shift in Central Nervous System Therapeutics

One of the key drivers of a shift in CNS drugs hinges on the success or failure of Biogen’s aducanumab for Alzheimer’s disease.

March 8, 2021
·
6 min read
·
Mark Terry
Drug Development

CytoDyn’s Vyrologix Shortens Hospital Stays, Improves Survival in Severe COVID-19

The findings from the late-stage trial of Vyrologix have not been published, but CytoDyn said it is preparing a manuscript of the study data for submission.

March 8, 2021
·
2 min read
·
Brandon May
Drug Development

Antibody Drug Fails to Beat Placebo in Trial for Rare Inflammatory Skin Condition

AnaptysBio started the week with some disappointing news for its lead antibody drug imsidolimab.

March 8, 2021
·
1 min read
·
Kate Goodwin
Drug Development

Merck’s Fortunes Against COVID-19 Improve as Ridgeback Drug Shows Early Promise

Merck and Ridgeback Biotherapeutics announced preliminary results from Ridgeback’s Phase IIa trial of molnupiravir in COVID-19.

March 8, 2021
·
3 min read
·
Mark Terry
FDA

FDA Approves Gilead/Kite’s Yescarta as First CAR-T for Follicular Lymphoma

The U.S. FDA approved Gilead and Kite’s Yescarta (axicabtagene ciloleucel) for adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

March 8, 2021
·
3 min read
·
Mark Terry
Drug Development

Seres to Discontinue Microbiome Cancer Clinical Program

Microbiome company Seres Therapeutics announced the discontinuation of its Phase Ib trial of SER-401, an orally delivered consortia of bacteria that was intended to boost the efficacy of checkpoint inhibitors in patients with metastatic melanoma.

March 8, 2021
·
2 min read
·
Mark Zipkin
FDA

Following AstraZeneca’s Lead, Roche Pulls Checkpoint Inhibitor in Bladder Cancer

Roche announced it was voluntarily withdrawing the U.S. indication Tecentriq for in prior-platinum treated metastatic urothelial carcinoma (mUC) after failing to meet endpoints in confirmatory trials.

March 8, 2021
·
2 min read
·
Alex Keown
Policy

Russia Engaging in Anti-Pfizer Disinformation Campaign to Boost Sales of Sputnik V, U.S. Alleges

The Russian government is attempting to cast a negative light on the COVID-19 vaccine developed by Pfizer and BioNTech, as well as other vaccines, in order to boost sales of its own vaccine, Sputnik V, the government charged.

March 8, 2021
·
3 min read
·
Alex Keown
BioCapital

BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region

BWXT Medical Ltd. and Global Medical Solutions, Ltd. have entered into a joint venture to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific.

March 8, 2021
·
4 min read
Biotech Bay

NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth Conference

NovaBay Pharmaceuticals to Participate in Virtual 33 rd Annual Roth Conference

March 8, 2021
·
1 min read